Journal of Pediatric Epilepsy 2016; 05(01): 034-036
DOI: 10.1055/s-0035-1567852
Case Report
Georg Thieme Verlag KG Stuttgart · New York

A Case of Glucose Transporter 1 Deficiency Syndrome

Shilpa D. Kulkarni
1   Department of Pediatric Neurosciences, Bai Jerbai Wadia Hospital, Mumbai, Maharashtra, India
,
Varsha A. Patil
1   Department of Pediatric Neurosciences, Bai Jerbai Wadia Hospital, Mumbai, Maharashtra, India
,
Rafat J. Sayed
1   Department of Pediatric Neurosciences, Bai Jerbai Wadia Hospital, Mumbai, Maharashtra, India
,
Krishnakumar N. Shah
1   Department of Pediatric Neurosciences, Bai Jerbai Wadia Hospital, Mumbai, Maharashtra, India
› Author Affiliations
Further Information

Publication History

09 November 2014

01 March 2015

Publication Date:
23 November 2015 (online)

Abstract

Glucose transporter 1 deficiency syndrome (GLUT1 DS) is a treatable neurometabolic condition caused by impaired glucose transport across the blood–brain barrier. The phenotypic spectrum of this condition has expanded with complex movement disorders being increasingly recognized in affected patients. We present a 10-year-old boy who was brought to our institute with developmental delay, infantile-onset epilepsy with multiple seizure types, paroxysmal ataxia more marked in the morning, fatigability with leg pains, and behavioral issues. His cerebrospinal fluid (CSF) analysis showed hypoglycorrhachia with normal blood glucose, which clinched the diagnosis of GLUT1 DS. He responded very well to ketogenic diet. Thus, in case of refractory epilepsy or complex movement disorder, CSF analysis may provide a clue for the diagnosis of GLUT1 DS. Early recognition helps in prompt initiation of treatment with the ketogenic diet and leads to a favorable outcome.

 
  • References

  • 1 Klepper J. Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia 2008; 49 (Suppl. 08) 46-49
  • 2 Klepper J. GLUT1 deficiency syndrome in clinical practice. Epilepsy Res 2012; 100 (3) 272-277
  • 3 De Giorgis V, Veggiotti P. GLUT1 deficiency syndrome 2013: current state of the art. Seizure 2013; 22 (10) 803-811
  • 4 Ramm-Pettersen A, Nakken KO, Skogseid IM , et al. Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study. Dev Med Child Neurol 2013; 55 (5) 440-447
  • 5 Leen WG, Klepper J, Verbeek MM , et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010; 133 (Pt 3): 655-670
  • 6 Afawi Z, Suls A, Ekstein D , et al. Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency. Epilepsia 2010; 51 (12) 2466-2469
  • 7 Tzadok M, Nissenkorn A, Porper K , et al. The many faces of Glut1 deficiency syndrome. J Child Neurol 2014; 29 (3) 349-359
  • 8 Brockmann K. The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 2009; 31 (7) 545-552
  • 9 Wang D, Pascual JM, Yang H , et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 2005; 57 (1) 111-118
  • 10 Klepper J, Leiendecker B. GLUT1 deficiency syndrome—2007 update. Dev Med Child Neurol 2007; 49 (9) 707-716
  • 11 Roubergue A, Apartis E, Mesnage V , et al. Dystonic tremor caused by mutation of the glucose transporter gene GLUT1. J Inherit Metab Dis 2011; 34 (2) 483-488
  • 12 Anand G, Padeniya A, Hanrahan D , et al. Milder phenotypes of glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol 2011; 53 (7) 664-668
  • 13 Ulate-Campos A, Fons C, Artuch R , et al. Alternating hemiplegia of childhood with a de novo mutation in ATP1A3 and changes in SLC2A1 responsive to a ketogenic diet. Pediatr Neurol 2014; 50 (4) 377-379
  • 14 De Vivo DC, Leary L, Wang D. Glucose transporter 1 deficiency syndrome and other glycolytic defects. J Child Neurol 2002; 17 (Suppl. 03) S15-S23 , discussion S24–S25